Levonelle (Levonorgestrel)

Levonorgestrel acts by binding to progesterone receptors, suppressing the luteinising hormone surge and thereby preventing ovulation. It also alters tubal motility and endometrial receptivity, which can hinder fertilisation and implantation of a fertilised egg.

The specific dose and regimen of Levonelle are determined by the prescribing healthcare professional. The product is supplied as a single‑dose tablet, and the prescriber will decide the appropriate use based on clinical guidelines and patient circumstances.

Levonelle is intended for use after unprotected intercourse and is not a regular contraceptive. It is not recommended for use during an established pregnancy. Limited data are available for breastfeeding; however, the amount transferred to breast milk is low, and occasional use is generally considered acceptable after consulting a healthcare provider.

To order Levonelle, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Levonelle contains levonorgestrel, a progestogen that is effective when taken within 72‑120 hours after intercourse. Compared with copper‑IUD insertion, which is the most effective method, levonorgestrel tablets are less effective but more convenient. Another oral option, ulipristal acetate, may retain efficacy slightly longer, but levonorgestrel remains widely used and readily available.

Levonelle tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and store out of reach of children.

Levonelle is taken orally as a single tablet. The tablet should be swallowed whole with water as soon as possible after unprotected sexual intercourse, ideally within the first 72 hours, but it remains effective up to 120 hours.

Serious but rare risks include severe allergic reactions (anaphylaxis), ectopic pregnancy, and thromboembolic events. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, severe abdominal pain, chest pain, or persistent vomiting.

Levonelle should be avoided by individuals with a known hypersensitivity to levonorgestrel or any tablet excipients. It is also not recommended for women who are already pregnant, have a confirmed or suspected ectopic pregnancy, or have conditions that contraindicate hormonal contraception without prior medical evaluation.